Cardiogenic shock is a serious life-threatening condition affecting almost 10% of patients suffering from acute coronary syndrome. When untreated, it can rapidly progress causing collapse of circulation and sudden death. Despite contemporary improvements in diagnostic and treatment options, mortality remains incredibly high, reaching nearly 50%.
Currently available mechanical circulatory support devices can replace the function of the heart and/or lungs, thereby essentially eliminating the primary cause. However, cardiogenic shock is not only an isolated decrease in cardiac function but a rapidly progressing multiorgan dysfunction accompanied by severe cellular and metabolic abnormalities. The window for successful treatment is relatively narrow and when missed, even the elimination of underlying primary cause is not enough to reverse this vicious circle.
Full text/protocol - on request
Speaker: Allan Bohm, Premedix Academy
Date: 24 March 2023
Time: 14:50 - 15:10
Speaker: Allan Bohm, Premedix Academy
Date: 25 March 2023
Time: 08:45 - 09:00
The first results presented at the 2022 ESC Acute CardioVascular Care congress received positive feedback.
After external validation our model showed an exciting predictive capability: AUC of 0.84 surpassing current validated CS models (e.g., the ORBI score).
We started an international cooperation not only in the framework of patient data collection, but also planning, design and management of the entire #STOPSHOCK project.
Our online cloud-based electronic case report form is up and running, continually tested and ready for final variable selection.
Online calculator is online.
Our smartphone applications (Android and iOS) for prospective model validation and data collection are in beta-testing.
#STOP SHOCK is designed to allow self-improvement. New potential CS predictors can be added and tested in the future ensuring that the model keeps pace with contemporary research.
Sign-up your institution for prospective validation
Get access to dedicated STOP SHOCK smartphone applications and work with us on prospective validation and continuous model improvement.
Sign-up your institution for STOP SHOCK CS registry
Help with retrospective or prospective patient registration. Established ACS STOP SHOCK patient database will be available to all contributing members with STOP SHOCK not being the end but a beginning of international research cooperation on cardiogenic shock.
#STOPSHOCK
Score To Predict SHOCK